Elevated plasma paroxetine concentrations in a patient treated with a combination of paroxetine and pindolol

International Journal of Psychiatry in Clinical Practice

Volumn 2, Issue 3, 1998, Pages 225-227

  Olver, James S ^a   Burrows, Graham D ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Andole; Depression; Drug interactions; Paroxetine; Plasma concentrations

Indexed keywords

PAROXETINE; PINDOLOL;

ADULT; ARTICLE; BEHAVIOR THERAPY; CASE REPORT; COGNITIVE THERAPY; DEPRESSION; DRUG BLOOD LEVEL; FEMALE; HUMAN; PANIC; PRIORITY JOURNAL;

EID: 0031707040     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.3109/13651509809115361     Document Type: Article

References (12)

1. Burrows GD, Norman TR, Judd FK (1994) Definition and differential diagnosis of treatment resistant depression. Int Clin Psychophaem 9 (suppl 2): 5-10.
2. Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51: 248-51.
3. Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drags in the treatment of major depression. J Clin Psychopharmacol 15: 217-22.
4. Perez V, Gilaberte I, Faries D et al (1997) Randomised double-blind placebo controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 349: 1594-97.
5. Berman RN, Darnal AM, Miller HL et al (1997) Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double blind placebo controlled trial. Am J Psychiatry 154: 37-43.
6. Tome MB, Isaac NT, Hart R, Holland C (1997) Paroxetine and pindolol: A randomised trial of scrotonergic autoreceptor blockade in the reduction of antidepressant latency. Int Clin Psychopharm 12: 81-9.
7. Hamilton M (1967) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
8. Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-71.
9. Sukow RV, Zhang MF, Cooper TB (1992) Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescent detection after precolumn derivatisation. Clin Chem 38: 1756-61.
10. Crewe HK, Lennard MS, Tucker GT et al (1992) The effect of selective serotonin reuptake inhibitors on cytochrome P45011D6 (CYP11D6) in human liver microsomes. Br J Clin Pharmacol 34: 262-5.
11. Otton SV, Ball SE, Cheung SW et al. (1994) Comparative inhibition of the polymorphic enzyme CYP11D6 by venlafaxine and other 5HT reuptake inhibitors. Clin Pharmacol Ther 55: 141.
12. Ferrari S, Leeman T, Dayer P (1991) The role of lipophilicity in the inhibition of polymorphic cytochrome P45011D6 oxidation by B-blocking agents in vitro. Life Sci 48: 2259-65.